Evidence map›Paper›PMID 33174059›Full record

ArticleMolecular medicine reports2020

Small molecular compounds efficiently convert human fibroblasts directly into neurons.

Jijuan Yang, Huimei Cao, Shengnan Guo, Hong Zhu, Hong Tao, Linna Zhang, Zhangping Chen, Tao Sun, Shuhong Chi, Qikuan Hu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Experimental study on small molecule combinations inducing reprogramming of rat fibroblasts into functional neurons.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. [VCR, a Small Molecule Compound, Induces Reprogramming of Rat Fibroblasts into Neural Progenitor Cells under Hypoxic Condition].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jijuan YangDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Huimei CaoDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Shengnan GuoDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Hong ZhuDepartment of Rheumatology, The General Hospital of Ningxia Medical University.
Hong TaoDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Linna ZhangDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Zhangping ChenDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Tao SunNingxia Key Laboratory of Cerebrocranial Disease, Basic Medical School of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Shuhong ChiDepartment of Rheumatology, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Qikuan HuDepartment of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No effective treatment is currently available for neurodegenerative diseases, and existing pharmacotherapy is inconsistent with severe side effects. Cell replacement therapy is promising for neurodegenerative disease treatment, and the induction of neurons is an unmet need for such therapy. The present study investigated the potential of a combined medium composed of conditioned medium and eight small molecular compounds in reprogramming human foreskin fibroblasts (HFFs) into neurons. HFFs were cultured from foreskin and then induced by small molecules to generate neurons. The results demonstrated that the conditioned medium containing forskolin, RepSox, SP600125, CHIR99021, Go6983, Y‑27632, IXS9 and I‑BET151 effectively induced human fibroblasts to change into neurons in vitro. Following a 30‑day induction, the cells exhibited neuronal properties as determined by morphological and phenotypical alterations. The induced cells exhibited expression of neuronal markers, including class III β‑tubulin, microtubule‑associated protein 2, vesicular glutamate transporter 1 and γ‑aminobutyric acid, accompanied by increased expression of neuronal transcription factors, including neuronal differentiation 1 and achaete‑scute family bHLH transcription factor 1, and decreased expression levels of fibroblast‑specific genes. Furthermore, these cells also exhibited electrophysiological properties of neurons. Notably, the course of cell morphological alterations demonstrated the differentiation of fibroblasts into neurons. The present study provided a novel combination of existing small molecular compounds that efficiently reprogramed human fibroblasts into neurons.

Indexed as

AmidesAnthracenesCell DifferentiationCells, CulturedCellular ReprogrammingCellular Reprogramming TechniquesColforsinCulture Media, ConditionedFibroblastsForeskinHumansIndolesMaleMaleimidesNerve Tissue ProteinsNeurodegenerative Diseases2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimideAmidesAnthracenesChir 99021ColforsinCulture Media, ConditionedIndolesMaleimidesNerve Tissue ProteinspyrazolanthronePyrazolesPyridinesPyrimidinesRepSoxTranscription FactorsY 27632

Identifiers

PMID33174059
PMCPMC7646904
OpenAlexW3090664178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.